Literature DB >> 7435119

Testosterone metabolism in human bone.

H U Schweikert, W Rulf, N Niederle, H E Schäfer, E Keck, F Krück.   

Abstract

The conversion of [1,2,6,7-3H]testosterone to [3H]dihydrotestosterone has been assessed in ground sp¿ongiosa of normal and osteoporotic bone. The tissue was obtained from 23 patients, 18 women, 3 men and 2 children who were undergoing orthopedic surgery. The formation of dihydrotestosterone was demonstrated in all samples examined. The half maximum rate of dihydrotestosterone formation occurred at a substrate concentration of 0.3 microM a value similar to that reported for dihydrotestosterone formation in other androgen target organs. Under the standardized conditions utilized in this study the rate of dihydrotestosterone formation did not differ significantly in normal as compared to osteoporotic bone. Furthermore, the conversion of testosterone to androstenedione was also similar in osteoporotic and normal bone. Based on these studies it seems reasonable to conclude that dihydrotestosterone rather than testosterone is the active intracellular androgen in human bone since in other androgen target tissue androgen action is mediated by dihydrotestosterone if 5 alpha-reductase is present.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7435119     DOI: 10.1530/acta.0.0950258

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  12 in total

1.  Aromatization of androgens is important for skeletal maintenance of aged male rats.

Authors:  D Vanderschueren; E Van Herck; R De Coster; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

Review 2.  Anabolic-androgenic steroids: In cell culture.

Authors:  C D Kochakian; A A Welder
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-06       Impact factor: 2.416

3.  Prolactinoma in a middle-aged man with an osteoporotic fracture.

Authors:  S D Taylor; T M Kelly
Journal:  West J Med       Date:  1989-07

Review 4.  Androgens and bone.

Authors:  D Vanderschueren; R Bouillon
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

5.  Metabolism of 25-hydroxycholecalciferol by human bone.

Authors:  E Keck; R Durdel; T West; F Krück; W Meier; U Hennes; H L Krüskemper; H U Schweikert
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

6.  Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model.

Authors:  Shirly Sieh; Amy A Lubik; Judith A Clements; Colleen C Nelson; Dietmar W Hutmacher
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

7.  Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues.

Authors:  Shuyuan Yeh; Meng-Yin Tsai; Qingquan Xu; Xiao-Min Mu; Henry Lardy; Ko-En Huang; Hank Lin; Shauh-Der Yeh; Saleh Altuwaijri; Xinchang Zhou; Lianping Xing; Brendan F Boyce; Mien-Chie Hung; Su Zhang; Lin Gan; Chawnshang Chang; Min-Chi Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

8.  Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate.

Authors:  E O Grecu; A Weinshelbaum; R Simmons
Journal:  Calcif Tissue Int       Date:  1990-05       Impact factor: 4.333

9.  Influence of testosterone and dihydrotestosterone on bone-matrix induced endochondral bone formation.

Authors:  S P Kapur; A H Reddi
Journal:  Calcif Tissue Int       Date:  1989-02       Impact factor: 4.333

10.  Androgen resistance and deficiency have different effects on the growing skeleton of the rat.

Authors:  D Vanderschueren; E Van Herck; P Geusens; A Suiker; W Visser; K Chung; R Bouillon
Journal:  Calcif Tissue Int       Date:  1994-09       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.